Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target
- PMID: 11035814
- PMCID: PMC18819
- DOI: 10.1073/pnas.220428097
Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target
Abstract
To address the dual needs for improved methods to assess potential health risks associated with chemical exposure in aquatic environments and for new models for in vivo mutagenesis studies, we developed transgenic fish that carry multiple copies of a bacteriophage lambda vector that harbors the cII gene as a mutational target. We adapted a forward mutation assay, originally developed for lambda transgenic rodents, to recover cII mutants efficiently from fish genomic DNA by lambda in vitro packaging. After infecting and plating phage on a hfl- bacterial host, cII mutants were detected under selective conditions. We demonstrated that many fundamental features of mutation analyses based on lambda transgenic rodents are shared by transgenic fish. Spontaneous mutant frequencies, ranging from 4.3 x 10(-5) in liver, 2.9 x 10(-5) in whole fish, to 1.8 x 10(-5) in testes, were comparable to ranges in lambda transgenic rodents. Treatment with ethylnitrosourea resulted in concentration-dependent, tissue-specific, and time-dependent mutation inductions consistent with known mechanisms of action. Frequencies of mutants in liver increased insignificantly 5 days after ethylnitrosourea exposure, but increased 3.5-, 5.7- and 6. 7-fold above background at 15, 20, and 30 days, respectively. Mutants were induced 5-fold in testes at 5 days, attaining a peak 10-fold induction 15 days after treatment. Spontaneous and induced mutational spectra in the fish were also consistent with those of lambda transgenic rodent models. Our results demonstrate the feasibility of in vivo mutation analyses using transgenic fish and illustrate the potential value of fish as important comparative animal models.
Figures


Similar articles
-
Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.Mutagenesis. 1998 Sep;13(5):487-97. doi: 10.1093/mutage/13.5.487. Mutagenesis. 1998. PMID: 9800194
-
Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.Environ Mol Mutagen. 1999;33(3):249-56. Environ Mol Mutagen. 1999. PMID: 10334627
-
The Lambda Select cII Mutation Detection System.J Vis Exp. 2018 Apr 26;(134):57510. doi: 10.3791/57510. J Vis Exp. 2018. PMID: 29757290 Free PMC article.
-
Just how does the cII selection system work in Muta Mouse?Environ Mol Mutagen. 2001;37(4):290-6. doi: 10.1002/em.1035. Environ Mol Mutagen. 2001. PMID: 11424178 Review.
-
Trangenic fish as models in environmental toxicology.ILAR J. 2001;42(4):322-9. doi: 10.1093/ilar.42.4.322. ILAR J. 2001. PMID: 11581523 Review.
Cited by
-
Chronic dietary exposure of zebrafish to PAH mixtures results in carcinogenic but not genotoxic effects.Environ Sci Pollut Res Int. 2014 Dec;21(24):13833-49. doi: 10.1007/s11356-014-2923-7. Epub 2014 Apr 30. Environ Sci Pollut Res Int. 2014. PMID: 24777325
-
Mycobacterium marinum produces long-term chronic infections in medaka: a new animal model for studying human tuberculosis.Comp Biochem Physiol C Toxicol Pharmacol. 2007 Feb;145(1):45-54. doi: 10.1016/j.cbpc.2006.07.012. Epub 2006 Aug 12. Comp Biochem Physiol C Toxicol Pharmacol. 2007. PMID: 17015042 Free PMC article.
-
Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes).Comp Biochem Physiol C Toxicol Pharmacol. 2009 Mar;149(2):152-60. doi: 10.1016/j.cbpc.2008.09.011. Epub 2008 Sep 24. Comp Biochem Physiol C Toxicol Pharmacol. 2009. PMID: 18929684 Free PMC article.
-
The challenges of implementing pathogen control strategies for fishes used in biomedical research.Comp Biochem Physiol C Toxicol Pharmacol. 2012 Jan;155(1):160-6. doi: 10.1016/j.cbpc.2011.06.007. Epub 2011 Jun 25. Comp Biochem Physiol C Toxicol Pharmacol. 2012. PMID: 21726668 Free PMC article. Review.
-
Fish can be first--advances in fish transgenesis for commercial applications.Transgenic Res. 2003 Aug;12(4):379-89. doi: 10.1023/a:1024267416522. Transgenic Res. 2003. PMID: 12885160 Review.
References
-
- Mirsalis J C, Monforte J A, Winger R A. Annu Rev Pharmacol Toxicol. 1995;35:135–164. - PubMed
-
- Summer W C, Glazer P M, Malkevich D. Mutat Res. 1989;220:263–268. - PubMed
-
- Gossen J A, De Leeuw W J, Molijin A C, Vigj J. BioTechniques. 1993;14:624–629. - PubMed
-
- Walker V E, Andrews J L, Upton P B, Skopek T R, De Boer J G, Walker D M, Shi X, Sussman H E, Gorelick N J. Environ Mol Mutagen. 2000;34:167–181. - PubMed
-
- Bailey G S, Hendricks J D, Dashwood R. Mutat Res. 1992;267:243–250. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources